ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 872,99
0,17%
DAX
18 726,76
-0,21%
Brent Oil
82,425
-1,32%
Bitcoin
69 530,83
-2,69%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aerpio Pharmaceuticals Inc (ARPO)

  7. Aerpio Pharmaceuticals Inc (ARPO) Actualités

ARPO

Aerpio Pharmaceuticals (ARPO)

Aerpio Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ARPO
DateHeureSourceTitreSymboleSociété
21/06/202312h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
16/06/202321h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/04/202319h25Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/04/202318h47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/04/202318h43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202322h19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202322h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202312h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/03/202322h08Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
14/02/202312h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
09/11/202222h16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARPOAerpio Pharmaceuticals Inc
07/11/202212h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARPOAerpio Pharmaceuticals Inc
04/11/202221h06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
26/10/202222h50Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
11/10/202218h28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ARPOAerpio Pharmaceuticals Inc
04/10/202222h02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARPOAerpio Pharmaceuticals Inc
26/09/202223h28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
21/03/202211h08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARPOAerpio Pharmaceuticals Inc
07/09/202123h26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ARPOAerpio Pharmaceuticals Inc
01/09/202101h53Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
09/07/202113h31TipRanksPenny Stock Aerpio Pharmaceuticals’ Merger With Aadi Makes It A Buy, Says AnalystNASDAQ:ARPOAerpio Pharmaceuticals Inc
21/06/202113h31Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
17/09/202013h00GlobeNewswire Inc.Aravive Appoints Michael W. Rogers to Board of DirectorsNASDAQ:ARPOAerpio Pharmaceuticals Inc
01/09/202022h30PR Newswire (US)Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-...NASDAQ:ARPOAerpio Pharmaceuticals Inc
27/05/202022h30PR Newswire (US)Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation ...NASDAQ:ARPOAerpio Pharmaceuticals Inc
12/05/202022h30GlobeNewswire Inc.Aerpio Announces Amended Licensing Deal with Gossamer Bio on its Inflammatory Bowel Disease (IBD) Product Candidate GB004 (fo...NASDAQ:ARPOAerpio Pharmaceuticals Inc
17/04/202022h46Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
12/03/202022h00GlobeNewswire Inc.Aerpio Pharmaceuticals to Report Year Ended December 31, 2019 Financial Results on Monday, March 16, 2020NASDAQ:ARPOAerpio Pharmaceuticals Inc
08/02/202000h20Business WireAerpio Pharmaceuticals Presents Data from Fifth Patient Cohort Showing Potential of Topical Ocular Formulation of AKB-9778 Pr...NASDAQ:ARPOAerpio Pharmaceuticals Inc
08/01/202014h43Business WireTopical Ocular Formulation of Aerpio Pharmaceutical’s AKB-9778 Product Candidate Produced IOP Lowering with Minimal Hyperem...NASDAQ:ARPOAerpio Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ARPO

Dernières Valeurs Consultées

EU
AF
Air FranceKLM
EU
BNP
BNP Paribas
EU
RNO
Renault
EU
MC
Lvmh Moet Hennessy Louis...
EU
CS
Axa
EU
AI
Air Liquide
EU
HO
Thales
NASDAQ
AMZN
Amazon.com
EU
PX4
SBF 120
EU
RI
Pernod Ricard
EU
VK
Vallourec
EU
LR
Legrand
NYSE
JPM
JP Morgan Chase
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés